The pahtway p173 has 73 genes in the original annotation. Currently, there are 59 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
1147 | CHUK | IKBKA | IKK-alpha | IKK1 | IKKA | NFKBIKA | TCF16 | conserved helix-loop-helix ubiquitous kinase | | | 10q24-q25 |
3265 | HRAS | C-BAS/HAS | C-H-RAS | C-HA-RAS1 | CTLO | H-RASIDX | HAMSV | HRAS1 | RASH1 | p21ras | Harvey rat sarcoma viral oncogene homolog | | | 11p15.5 |
5970 | RELA | NFKB3 | p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | | | 11q13 |
595 | CCND1 | BCL1 | D11S287E | PRAD1 | U21B31 | cyclin D1 | | | 11q13 |
9846 | GAB2 | - | GRB2 associated binding protein 2 | | | 11q14.1 |
867 | CBL | C-CBL | CBL2 | FRA11B | NSLL | RNF55 | Cbl proto-oncogene, E3 ubiquitin protein ligase | | | 11q23.3 |
3845 | KRAS | C-K-RAS | CFC2 | K-RAS2A | K-RAS2B | K-RAS4A | K-RAS4B | KI-RAS | KRAS1 | KRAS2 | NS | NS3 | RALD | RASK2 | Kirsten rat sarcoma viral oncogene homolog | | | 12p12.1 |
1027 | CDKN1B | CDKN4 | KIP1 | MEN1B | MEN4 | P27KIP1 | cyclin-dependent kinase inhibitor 1B | | | 12p13.1-p12 |
1019 | CDK4 | CMM3 | PSK-J3 | cyclin-dependent kinase 4 | | | 12q14 |
4193 | MDM2 | ACTFS | HDMX | hdm2 | MDM2 proto-oncogene | | | 12q14.3-q15 |
5781 | PTPN11 | BPTP3 | CFC | JMML | METCDS | NS1 | PTP-1D | PTP2C | SH-PTP2 | SH-PTP3 | SHP2 | protein tyrosine phosphatase, non-receptor type 11 | | | 12q24 |
5925 | RB1 | OSRC | PPP1R130 | RB | p105-Rb | pRb | pp110 | retinoblastoma 1 | | | 13q14.2 |
4792 | NFKBIA | IKBA | MAD-3 | NFKBI | NFKB inhibitor alpha | | | 14q13 |
6655 | SOS2 | NS9 | SOS Ras/Rho guanine nucleotide exchange factor 2 | | | 14q21 |
7043 | TGFB3 | ARVD | ARVD1 | LDS5 | RNHF | TGF-beta3 | transforming growth factor beta 3 | | | 14q24 |
207 | AKT1 | AKT | CWS6 | PKB | PKB-ALPHA | PRKBA | RAC | RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 | | | 14q32.32 |
399694 | SHC4 | RaLP | SHCD | SHC (Src homology 2 domain containing) family member 4 | | | 15q21.1-q21.2 |
5604 | MAP2K1 | CFC3 | MAPKK1 | MEK1 | MKK1 | PRKMK1 | mitogen-activated protein kinase kinase 1 | | | 15q22.1-q22.33 |
5595 | MAPK3 | ERK-1 | ERK1 | ERT2 | HS44KDAP | HUMKER1A | P44ERK1 | P44MAPK | PRKM3 | p44-ERK1 | p44-MAPK | mitogen-activated protein kinase 3 | | | 16p11.2 |
23533 | PIK3R5 | F730038I15Rik | FOAP-2 | P101-PI3K | p101 | phosphoinositide-3-kinase regulatory subunit 5 | | | 17p13.1 |
7157 | TP53 | BCC7 | LFS1 | P53 | TRP53 | tumor protein p53 | | | 17p13.1 |
1398 | CRK | CRKII | p38 | v-crk avian sarcoma virus CT10 oncogene homolog | | | 17p13.3 |
6776 | STAT5A | MGF | STAT5 | signal transducer and activator of transcription 5A | | | 17q11.2 |
2885 | GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | NCKAP2 | growth factor receptor bound protein 2 | | | 17q24-q25 |
4089 | SMAD4 | DPC4 | JIP | MADH4 | MYHRS | SMAD family member 4 | | | 18q21.1 |
5605 | MAP2K2 | CFC4 | MAPKK2 | MEK2 | MKK2 | PRKMK2 | mitogen-activated protein kinase kinase 2 | | | 19p13.3 |
7040 | TGFB1 | CED | DPD1 | LAP | TGFB | TGFbeta | transforming growth factor beta 1 | | | 19q13.1 |
208 | AKT2 | HIHGHH | PKBB | PKBBETA | PRKBB | RAC-BETA | v-akt murine thymoma viral oncogene homolog 2 | | | 19q13.1-q13.2 |
5296 | PIK3R2 | MPPH | MPPH1 | P85B | p85 | p85-BETA | phosphoinositide-3-kinase regulatory subunit 2 | | | 19q13.2-q13.4 |
4893 | NRAS | ALPS4 | CMNS | N-ras | NCMS | NRAS1 | NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog | | | 1p13.2 |
3065 | HDAC1 | GON-10 | HD1 | RPD3 | RPD3L1 | histone deacetylase 1 | | | 1p34 |
8503 | PIK3R3 | p55 | p55-GAMMA | p55PIK | phosphoinositide-3-kinase regulatory subunit 3 | | | 1p34.1 |
1870 | E2F2 | E2F-2 | E2F transcription factor 2 | | | 1p36 |
5293 | PIK3CD | APDS | IMD14 | P110DELTA | PI3K | p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | | | 1p36.2 |
10000 | AKT3 | MPPH | MPPH2 | PKB-GAMMA | PKBG | PRKBG | RAC-PK-gamma | RAC-gamma | STK-2 | v-akt murine thymoma viral oncogene homolog 3 | | | 1q44 |
598 | BCL2L1 | BCL-XL/S | BCL2L | BCLX | Bcl-X | PPP1R52 | BCL2 like 1 | | | 20q11.21 |
861 | RUNX1 | AML1 | AML1-EVI-1 | AMLCR1 | CBF2alpha | CBFA2 | EVI-1 | PEBP2aB | PEBP2alpha | runt related transcription factor 1 | | | 21q22.3 |
1399 | CRKL | - | v-crk avian sarcoma virus CT10 oncogene homolog-like | | | 22q11.21 |
5594 | MAPK1 | ERK | ERK-2 | ERK2 | ERT1 | MAPK2 | P42MAPK | PRKM1 | PRKM2 | p38 | p40 | p41 | p41mapk | p42-MAPK | mitogen-activated protein kinase 1 | | | 22q11.21 |
613 | BCR | ALL | BCR1 | CML | D22S11 | D22S662 | PHL | breakpoint cluster region | | | 22q11.23 |
7048 | TGFBR2 | AAT3 | FAA3 | LDS1B | LDS2 | LDS2B | MFS2 | RIIC | TAAD2 | TGFR-2 | TGFbeta-RII | transforming growth factor beta receptor II | | | 3p22 |
5894 | RAF1 | CMD1NN | CRAF | NS5 | Raf-1 | c-Raf | Raf-1 proto-oncogene, serine/threonine kinase | | | 3p25 |
868 | CBLB | Cbl-b | Nbla00127 | RNF56 | Cbl proto-oncogene B, E3 ubiquitin protein ligase | | | 3q13.11 |
5291 | PIK3CB | P110BETA | PI3K | PI3KBETA | PIK3C1 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | | | 3q22.3 |
2122 | MECOM | AML1-EVI-1 | EVI1 | MDS1 | MDS1-EVI1 | PRDM3 | RUSAT2 | MDS1 and EVI1 complex locus | | | 3q26.2 |
5290 | PIK3CA | CLOVE | CWS5 | MCAP | MCM | MCMTC | PI3K | p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | | | 3q26.3 |
1487 | CTBP1 | BARS | C-terminal binding protein 1 | | | 4p16 |
4790 | NFKB1 | CVID12 | EBP-1 | KBF1 | NF-kB1 | NF-kappa-B | NF-kappaB | NFKB-p105 | NFKB-p50 | NFkappaB | p105 | p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | | | 4q24 |
5295 | PIK3R1 | AGM7 | GRB1 | IMD36 | p85 | p85-ALPHA | phosphoinositide-3-kinase regulatory subunit 1 | | | 5q13.1 |
1026 | CDKN1A | CAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1 | cyclin-dependent kinase inhibitor 1A | | | 6p21.2 |
1871 | E2F3 | E2F-3 | E2F transcription factor 3 | | | 6p22 |
3066 | HDAC2 | HD2 | RPD3 | YAF1 | histone deacetylase 2 | | | 6q21 |
1021 | CDK6 | MCPH12 | PLSTIRE | cyclin-dependent kinase 6 | | | 7q21-q22 |
673 | BRAF | B-RAF1 | BRAF1 | NS7 | RAFB1 | B-Raf proto-oncogene, serine/threonine kinase | | | 7q34 |
3551 | IKBKB | IKK-beta | IKK2 | IKKB | IMD15 | NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | | | 8p11.2 |
4609 | MYC | MRTL | MYCC | bHLHe39 | c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | | | 8q24.21 |
1029 | CDKN2A | ARF | CDK4I | CDKN2 | CMM2 | INK4 | INK4A | MLM | MTS-1 | MTS1 | P14 | P14ARF | P16 | P16-INK4A | P16INK4 | P16INK4A | P19 | P19ARF | TP16 | cyclin-dependent kinase inhibitor 2A | | | 9p21 |
53358 | SHC3 | N-Shc | NSHC | RAI | SHCC | SHC (Src homology 2 domain containing) transforming protein 3 | | | 9q22.1 |
25 | ABL1 | ABL | JTK7 | bcr/abl | c-ABL | c-ABL1 | p150 | v-abl | ABL proto-oncogene 1, non-receptor tyrosine kinase | | | 9q34.1 |